Effects of anti-tal-1 oligodeoxynucleotides in T-ALL cell lines

Cancer Gene Ther. 1997 Mar-Apr;4(2):84-90.

Abstract

Rearrangement of the gene tal-1 leads to transcriptional dysregulation and contributes to the formation of childhood T-cell acute lymphoblastic leukemia. Therefore, we tried to interfere with the transcription of the SIL/tal-1 fusion gene, the most common form of aberrant tal-1, by treatment with antisense oligodeoxynucleotides (ODNs). The potential of two different strategies was investigated, one targeting the cell line specific SIL/tal-1 fusion region, the other using an ODN complementary to tal-1 sequence downstream of the region not affected by any of the known types of tal-1 rearrangement. With both approaches a single-dose application of 3 mumol of ODN led to a significant antiproliferative effect of a about 25-60% in two T-ALL cell lines characterized by the SIL/tal-1 fusion gene. Investigation of the tal-1 mRNA level by reverse transcription-polymerase chain reaction was in concordance with these results: In both cell lines clearly less of the tal-1-specific fragment was generated after incubation with the antisense ODN tal-1 common than in the control experiments with a mismatched ODN or no ODN at all. Neither the antiproliferation antisense effect nor the downregulation of the steady state tal-1 mRNA level was observed in control cell lines bearing wildtype tal-1.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Basic Helix-Loop-Helix Transcription Factors
  • Cell Division / drug effects
  • DNA-Binding Proteins / drug effects
  • DNA-Binding Proteins / genetics*
  • Dose-Response Relationship, Drug
  • Humans
  • Intracellular Signaling Peptides and Proteins
  • Leukemia-Lymphoma, Adult T-Cell / drug therapy*
  • Leukemia-Lymphoma, Adult T-Cell / genetics*
  • Leukemia-Lymphoma, Adult T-Cell / pathology
  • Mutation
  • Oligonucleotides, Antisense / genetics
  • Oligonucleotides, Antisense / pharmacokinetics
  • Oligonucleotides, Antisense / pharmacology*
  • Oncogene Proteins, Fusion*
  • Proteins / genetics
  • Proto-Oncogene Proteins*
  • RNA, Messenger / biosynthesis
  • RNA, Messenger / drug effects
  • Recombinant Fusion Proteins / genetics
  • T-Cell Acute Lymphocytic Leukemia Protein 1
  • Transcription Factors*
  • Tumor Cells, Cultured

Substances

  • Basic Helix-Loop-Helix Transcription Factors
  • DNA-Binding Proteins
  • Intracellular Signaling Peptides and Proteins
  • Oligonucleotides, Antisense
  • Oncogene Proteins, Fusion
  • Proteins
  • Proto-Oncogene Proteins
  • RNA, Messenger
  • Recombinant Fusion Proteins
  • STIL protein, human
  • T-Cell Acute Lymphocytic Leukemia Protein 1
  • Transcription Factors
  • TAL1 protein, human